There is interest in developing a prediction model using MRI since mutations of the isocitrate dehydrogenase (IDH) gene have been shown to be a marker of oncogenesis and is one of the most specific biomarkers in the diagnostic classification of secondary glioblastoma multiforme [34]. Here, IDH1 is linked to glioblastoma.